These isolated CD133+ cancer cells were further verified that they were tumor initiating stem cells, i.e., CSCs, by in vitro tumorsphere assays in 96 well micro-plates and by in vivo tumor xenograft assays in SCID/Beige mice. This evidence concerns the gene PROM1 and neoplasm.